Stem Cell Therapies

Stem cells are a collective name for different types of cells with the ability for self-renewal, as well as development and maturation into more specialized cells. One of these types is mesenchymal stem cells (MSC).

Therapeutic effects of MSC can be attributed to several different properties of these cells. A key feature is the ability to regenerate tissues and organs, either by directly contributing to the regeneration of new tissue or by stimulating cells in a damaged tissue for improved self-repair.

Another important property of MSC is their anti-inflammatory effects through direct action on the immune system.

The medical potential of stem cells has been known for some time but has only in recent years begun to see an upswing in clinical drug development. This is explained by time-consuming development work of new production methods and scientific studies necessary to evaluate the effect of new treatment methods.

Stem cell therapy involves treatment with living cells, which means that both production and handling of drugs entail high demands on the best possible handling of these cells throughout the process for optimal effect of the final product.

The market for stem cell therapies

8MM: US, France, Germany, Italy, Spain, UK, Japan and China

There are only a few approved cell therapies on the market today, which shows that we are still in the early stages of this type of treatment. However, the area is expected to grow rapidly in the coming years due to several clinical successes that have accelerated investment in the sector.

The first MSC-based drug was approved by the European Medicines Agency EMA in 2018.

US Drug Administration estimates that approval of drugs based on cell and gene therapy will increase by 900 percent annually between 2020 and 2025.

GlobalData estimates that the area of ​​cell therapies will reach $ 3.1 billion by 2026.